Company intelligence / Profile preview

ARKRAY

Ownership: Private
Development stage: Commercial

Overview

ARKRAY develops and markets innovative diagnostic instruments—especially for diabetes care—including blood glucose meters, A1C analyzers, urinalysis systems, reagents, consumables, and data management software. The company holds a leading position in the long-term care market for blood glucose monitoring. Its products are used by healthcare professionals worldwide to improve patient outcomes through accurate point-of-care testing and comprehensive data solutions. There are no clinical trial results as the business focuses on commercialized medical devices.

Therapeutic areas: OtherEndocrinologyNephrology
Modalities: DeviceDiagnostic instrument (e.g., blood glucose meters)Software (data management for diagnostics)Reagent/Consumable (for clinical chemistry and urinalysis)Functional food material (nutraceuticals/health supplements)
Industry: Metabolite Diagnostics

Partnerships

Capital alliance with Boditech Med Inc.

Beyond the preview

Go deeper on ARKRAY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARKRAY.

Explore the full profile